145 related articles for article (PubMed ID: 17209266)
1. The prevalence and risk behaviours associated with the transmission of blood-borne viruses among ethnic-Vietnamese injecting drug users.
Hellard ME; Nguyen OK; Guy RJ; Jardine D; Mijch A; Higgs PG
Aust N Z J Public Health; 2006 Dec; 30(6):519-25. PubMed ID: 17209266
[TBL] [Abstract][Full Text] [Related]
2. Blood-borne virus infections among Australian injecting drug users: implications for spread of HIV.
Crofts N; Hopper JL; Milner R; Breschkin AM; Bowden DS; Locarnini SA
Eur J Epidemiol; 1994 Dec; 10(6):687-94. PubMed ID: 7672048
[TBL] [Abstract][Full Text] [Related]
3. Markers and risk factors for HCV, HBV and HIV in a network of injecting drug users in Melbourne, Australia.
Miller ER; Hellard ME; Bowden S; Bharadwaj M; Aitken CK
J Infect; 2009 May; 58(5):375-82. PubMed ID: 19328555
[TBL] [Abstract][Full Text] [Related]
4. Risks for HIV, HBV, and HCV infections among male injection drug users in northern Vietnam: a case-control study.
Quan VM; Go VF; Nam le V; Bergenstrom A; Thuoc NP; Zenilman J; Latkin C; Celentano DD
AIDS Care; 2009 Jan; 21(1):7-16. PubMed ID: 19085215
[TBL] [Abstract][Full Text] [Related]
5. Risk behaviours of young Indo-Chinese injecting drug users in Sydney and Melbourne.
Maher L; Sargent P; Higgs P; Crofts N; Kelsall J; Le TT
Aust N Z J Public Health; 2001; 25(1):50-4. PubMed ID: 11297303
[TBL] [Abstract][Full Text] [Related]
6. Differences in the social networks of ethnic Vietnamese and non-Vietnamese injecting drug users and their implications for blood-borne virus transmission.
Aitken CK; Higgs P; Bowden S
Epidemiol Infect; 2008 Mar; 136(3):410-6. PubMed ID: 17506918
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of HIV, hepatitis B and hepatitis C and associated risk behaviours amongst injecting drug users in three Afghan cities.
Nasir A; Todd CS; Stanekzai MR; Bautista CT; Botros BA; Scott PT; Strathdee SA; Tjaden J
Int J Drug Policy; 2011 Mar; 22(2):145-52. PubMed ID: 21146392
[TBL] [Abstract][Full Text] [Related]
8. Risk behaviors and antibody hepatitis B and C prevalence among injecting drug users in south-western Sydney, Australia.
Maher L; Chant K; Jalaludin B; Sargent P
J Gastroenterol Hepatol; 2004 Oct; 19(10):1114-20. PubMed ID: 15377287
[TBL] [Abstract][Full Text] [Related]
9. Demographic, risk behaviour and personal network variables associated with prevalent hepatitis C, hepatitis B, and HIV infection in injection drug users in Winnipeg, Canada.
Wylie JL; Shah L; Jolly AM
BMC Public Health; 2006 Sep; 6():229. PubMed ID: 16970811
[TBL] [Abstract][Full Text] [Related]
10. Frontloading: a risk factor for HIV and hepatitis C virus infection among injecting drug users in Berlin.
Stark K; Müller R; Bienzle U; Guggenmoos-Holzmann I
AIDS; 1996 Mar; 10(3):311-7. PubMed ID: 8882671
[TBL] [Abstract][Full Text] [Related]
11. Incidence of bloodborne virus infection and risk behaviours in a cohort of injecting drug users in Victoria, 1990-1995.
Crofts N; Aitken CK
Med J Aust; 1997 Jul; 167(1):17-20. PubMed ID: 9236754
[TBL] [Abstract][Full Text] [Related]
12. Vietnamese-speaking injecting drug users in Melbourne: the need for harm reduction programs.
Louie R; Krouskos D; Gonzalez M; Crofts N
Aust N Z J Public Health; 1998 Jun; 22(4):481-4. PubMed ID: 9659777
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of HIV/HCV/HBV infections and drug-related risk behaviours amongst IDUs recruited through peer-driven sampling in Iran.
Zamani S; Radfar R; Nematollahi P; Fadaie R; Meshkati M; Mortazavi S; Sedaghat A; Ono-Kihara M; Kihara M
Int J Drug Policy; 2010 Nov; 21(6):493-500. PubMed ID: 20483578
[TBL] [Abstract][Full Text] [Related]
14. Modelling the force of infection for hepatitis B and hepatitis C in injecting drug users in England and Wales.
Sutton AJ; Gay NJ; Edmunds WJ; Hope VD; Gill ON; Hickman M
BMC Infect Dis; 2006 Jun; 6():93. PubMed ID: 16762050
[TBL] [Abstract][Full Text] [Related]
15. HIV infection and risk, prevention, and testing behaviors among injecting drug users -- National HIV Behavioral Surveillance System, 20 U.S. cities, 2009.
Broz D; Wejnert C; Pham HT; DiNenno E; Heffelfinger JD; Cribbin M; Krishna N; Teshale EH; Paz-Bailey G;
MMWR Surveill Summ; 2014 Jul; 63(6):1-51. PubMed ID: 24990587
[TBL] [Abstract][Full Text] [Related]
16. Co-infection by human immuno deficiency virus, hepatitis B and hepatitis C virus in injecting drug users.
Devi KhS; Brajachand N; Singh HL; Singh YM
J Commun Dis; 2005 Mar; 37(1):73-7. PubMed ID: 16637404
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of HIV and other infections and injection behaviours among people who inject drugs in Addis Ababa, Ethiopia.
Demissie M; Johnston LG; Muleta M; Desyebelew D; Belete W; G/Egxiabehre A; Gezahegn N; Kassa D; Aseffa Y
Afr J AIDS Res; 2018 Sep; 17(3):259-264. PubMed ID: 30319040
[TBL] [Abstract][Full Text] [Related]
18. The 2004 Australian prison entrants' blood-borne virus and risk behaviour survey.
Butler T; Boonwaat L; Hailstone S; Falconer T; Lems P; Ginley T; Read V; Smith N; Levy M; Dore G; Kaldor J
Aust N Z J Public Health; 2007 Feb; 31(1):44-50. PubMed ID: 17333608
[TBL] [Abstract][Full Text] [Related]
19. Trends in hepatitis B virus, hepatitis C virus, and human immunodeficiency virus prevalence, risk behaviors, and preventive measures among Seattle injection drug users aged 18-30 years, 1994-2004.
Burt RD; Hagan H; Garfein RS; Sabin K; Weinbaum C; Thiede H
J Urban Health; 2007 May; 84(3):436-54. PubMed ID: 17356901
[TBL] [Abstract][Full Text] [Related]
20. Screening injecting drug users for sexually transmitted infections and blood borne viruses using street outreach and self collected sampling.
Bradshaw CS; Pierce LI; Tabrizi SN; Fairley CK; Garland SM
Sex Transm Infect; 2005 Feb; 81(1):53-8. PubMed ID: 15681724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
